Guessing
no more

News

Find here information about MNM and people we work with. In this section, we showcase about events and our achievements.

Krzysztof Bokiej is a speaker at Data Science Summit ML Edition

Krzysztof Bokiej - Head of Platform and Pipelines at MNM - is a speaker at the most important Machine Learning conference in Poland.

No items found.

MNM Bioscience joins ESMO Breast Cancer 2022

Breast cancer (BC) constitutes the most common female malignancy and nowadays molecular classification of subtypes is crucial to estimate a patient’s prognosis and administer appropriate treatment. It allows tailoring therapeutic strategy much more precisely than using a standalone IHC status.

No items found.

MNM Bioscience eyes cancer drug target discovery based on its AI algorithms

MNM Bioscience began as a bioinformatics company that curates data and then builds artificial intelligence-based algorithms, but it is now looking to branch out into oncology drug target discovery.

No items found.

5th DNA Repair/Replication Structures and Cancer Conference

MNM Bioscience presents its participation in the fifth DNA Repair/Replication Structures & Cancer conference (27 Apr 2022 – 01 May 2022), where speakers will focus on presenting the structural and mechanistic insights of dynamic complexes, operating in DNA repair and replication, transcription and other cancer-relevant events.

No items found.

MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project

We are thrilled to announce that MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project.

No items found.

Introducing Random Similarity Forests

In our recent paper, we introduce Random Similarity Forest, a machine learning algorithm capable of handling datasets with features of arbitrary data types while retaining each feature’s characteristic.

No items found.

Alliance Visionary Leaders “Future of Health & Healthcare” Roundtable

Since our world is changing rapidly, especially biotech and healthcare fields must actively adapt to those alterations. We can all learn from leaders in other industries to understand how our organizations and lives may be changed in the following years.

No items found.

MNM Bioscience announced that it had filed a provisional patent application

MNM Bioscience announced that it had filed a provisional patent application

No items found.

Distribution-based feature extraction from copy number and structural variants in whole-genome data

With entire genomes at hand, scientists can pinpoint DNA fragments responsible for different cancers and predict patient responses to cancer treatments. However, the sheer volume of whole-genome data makes it difficult to encode the characteristics of genomic variants as features for machine learning algorithms.

No items found.

Publication in Molecular Diagnosis & Therapy has been just released

MNM Biosciences, in co-operation with leading Polish cancer centers, has recently published a breakthrough publication concerning breast cancer diagnostics.

No items found.